Defective Medicines2018-11-16T14:58:49+00:00

Defective Medicines

Defective Medicines - Malcomson Law Solicitors - Dedicated Health Law Team.Defective Medicines – Malcomson Law Solicitors – Dedicated Health Law Team. Malcomson Law has a dedicated health law team with specific experience in representing people who have suffered severe side effects or had fatal complications caused by defective medicines. In 2004 the drug Vioxx was withdrawn from the U.S. market. This was due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) in patients on Vioxx. In May 2007, the Irish Medicines Board announced the suspension of all medicinal products containing the drug Nimesulide with immediate effect. Nimesulide is a non-steroidal anti-inflammatory drug for the treatment of acute pain, the symptomatic treatment of osteoarthritis and excessive menstrual pain. This was as a consequence of concerns over liver damage. The products affected included Mesulide and Aulin. Malcomson Law has provided representation to people affected by both Vioxx and Nimesulide.

Who is responsible for the Regulation of Medicines?

The Irish Medicines Board (IMB) plays a major role in the safeguarding of public health from the distribution of defective medicinal products. Pharmaceutical companies are required to advise of adverse and harmful reactions associated with the use of their products to the IMB. Healthcare professionals and consumers are encouraged to report any suspected adverse reaction associated with a medicinal product to the IMB.

What happens when a Medicine is found to be Defective?
When a medicine is found to be defective and poses a risk to public health, the manufacturer or Marketing Authorisation Holder is responsible for recalling the defective medicines and removing all the product batches from the market. The injuries caused by exposure to these dangerous drugs or other over-the-counter supplements can be permanent and life-threatening.

If you believe that you have suffered from the adverse side effects of a defective medicine that has been removed from the market, phone us at 01 8744 422 and a client care executive will be happy to help you. Alternatively please fill in our contact form here and a client care executive will contact you.

All our client care executives are non-lawyers with a considerable track record of helping people through the many difficult issues that arise during the process of a defective medicines claim. They will also organise an appointment with an experienced medical negligence solicitor.

Useful Links

How to Make a Complaint to the HSE.
U.S. Food and Drug Administration.

European Medicines Agency.
Irish Medicines Board.

Royal College of Physicians Ireland.

National Institute for Health and Clinical Excellence.

World Health Organisation.

The Cochrane Collaboration.
An Bord Altranais, Nursing Board.
Health Service Executive.

Medical Council.

The Lancet Medical Journal.

British Medical Journal.

Medscape.

This website uses cookies and third party services. Ok